These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25558964)

  • 1. Clinical assessment of organizational strategy: An examination of healthy adults.
    Banerjee P; White DA
    Psychol Assess; 2015 Jun; 27(2):726-32. PubMed ID: 25558964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
    Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social cognition and neurocognition as independent domains in psychosis.
    van Hooren S; Versmissen D; Janssen I; Myin-Germeys I; à Campo J; Mengelers R; van Os J; Krabbendam L
    Schizophr Res; 2008 Aug; 103(1-3):257-65. PubMed ID: 18434094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.
    Randhawa S; Walterfang M; Miller K; Scholes A; Mocellin R; Velakoulis D
    J Psychosom Res; 2007 Jul; 63(1):93-8. PubMed ID: 17586342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive deficit measures in schizophrenia: factor structure and clinical correlates.
    Lieh-Mak F; Lee PW
    Am J Psychiatry; 1997 Jun; 154(6 Suppl):39-46. PubMed ID: 9167543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive functioning in euthymic bipolar I and bipolar II patients.
    Dittmann S; Hennig-Fast K; Gerber S; Seemüller F; Riedel M; Emanuel Severus W; Langosch J; Engel RR; Möller HJ; Grunze HC
    Bipolar Disord; 2008 Dec; 10(8):877-87. PubMed ID: 19594503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive profile analysis in obsessive-compulsive disorder.
    Burdick KE; Robinson DG; Malhotra AK; Szeszko PR
    J Int Neuropsychol Soc; 2008 Jul; 14(4):640-5. PubMed ID: 18577293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between memory and executive functions in normal and pathological aging.
    Bisiacchi PS; Borella E; Bergamaschi S; Carretti B; Mondini S
    J Clin Exp Neuropsychol; 2008 Aug; 30(6):723-33. PubMed ID: 18608665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable?
    Heinrichs RW; Ammari N; McDermid Vaz S; Miles AA
    Schizophr Res; 2008 Feb; 99(1-3):149-54. PubMed ID: 18031992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized cognitive testing in epilepsy (CCTE): a new method for cognitive screening.
    Kurzbuch K; Pauli E; Gaál L; Kerling F; Kasper BS; Stefan H; Hamer H; Graf W
    Seizure; 2013 Jul; 22(6):424-32. PubMed ID: 22999215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive estimation and its assessment.
    Gansler DA; Varvaris M; Swenson L; Schretlen DJ
    J Clin Exp Neuropsychol; 2014; 36(6):559-68. PubMed ID: 24835509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.
    Bowie CR; Leung WW; Reichenberg A; McClure MM; Patterson TL; Heaton RK; Harvey PD
    Biol Psychiatry; 2008 Mar; 63(5):505-11. PubMed ID: 17662256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the uses of the total score and the domain scores in the Cognitive Abilities Screening Instrument, Chinese version (CASI C-2.0): results of confirmatory factor analysis.
    Tsai RC; Lin KN; Wang HJ; Liu HC
    Int Psychogeriatr; 2007 Dec; 19(6):1051-63. PubMed ID: 17451615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing speed in the aging process: screening criteria for the Spanish Quick Test of Cognitive Speed.
    Subirana-Mirete J; Bruna O; Virgili C; Signo S; Palma C
    Percept Mot Skills; 2014 Oct; 119(2):417-29. PubMed ID: 25244555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive estimation impairment in Alzheimer disease and mild cognitive impairment.
    Levinoff EJ; Phillips NA; Verret L; Babins L; Kelner N; Akerib V; Chertkow H
    Neuropsychology; 2006 Jan; 20(1):123-32. PubMed ID: 16460228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational strategy use in obsessive-compulsive disorder.
    Roth RM; Milovan DL; Baribeau J; O'Connor K; Todorov C
    Psychiatry Res; 2004 Oct; 128(3):267-72. PubMed ID: 15541784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance variability as a new theoretical mechanism regarding eating disorders and cognitive processing.
    Ferraro FR; Wonderlich S; Jocic Z
    J Clin Psychol; 1997 Feb; 53(2):117-21. PubMed ID: 9029341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor planning is deficient in recent-onset schizophrenia.
    Grootens KP; Vermeeren L; Verkes RJ; Buitelaar JK; Sabbe BG; van Veelen N; Kahn RS; Hulstijn W
    Schizophr Res; 2009 Feb; 107(2-3):294-302. PubMed ID: 19008079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.